... 2. Company profile 3. Organizational Structure 4. Product Line 5. Market Scenario 6. Business level Strategy Pursued 7. Competitive Advantage 8. SWOT Analysis 9. Possible Measures to Improve Performance 10. Relationship between Business Level Strategy and Performance 11. What I Learned 12. Conclusion Historical Background Beximco Pharma is a leading edge pharmaceutical company and is a member of the Beximco Group, the largest private sector industrial conglomerate in Bangladesh. The firm started operation in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of USA and now have grown to become nation's one of the leading pharmaceutical companies, supplying more than 10% of country's total medicine need. Today Beximco Pharma manufactures and markets its own `branded generics' for almost all diseases from AIDS to cancer, from infection to sthma, from hypertensio to diabetes for both national and international markets. Company Profile Beximco Pharma manufactures a range of dosage forms including tablets, capsules, dry...
Words: 2662 - Pages: 11
...Pharmaceuticals Limited (BPL) is a part of Beximco Group, the largest private sector industrial conglomerate in Bangladesh. BPL develops, manufactures and markets both finished dosage form branded generic pharmaceutical products and active pharmaceutical ingredients (APIs), with products including solid dose forms, Metered Dose Inhalers, Nasal Sprays, Large Volume Intravenous Fluids, Suppositories, and Creams/Ointments. BPL produces and markets 'branded generics' for most diseases ranging from AIDS to cancer, from infection to asthma, from hypertension to diabetes, for both national and international markets. The company also manufactures active pharmaceutical ingredients and intravenous fluids and contract manufacture for major international brands of leading multinational companies. BPL utilizes state of the art manufacturing facilities. BPL also has outstanding reverse engineering capabilities. Incorporated in 1976, BPL started off as a distributor of pharmaceutical products. It imported products from global MNCs such as Bayer AG of Germany and Upjohn Inc. of USA and sold them in the local market. It eventually graduated to a manufacturer and distributor of these products in local market under licensing agreements. During the early 80s, BPL launched its own products in the local market. Beximco started its exports operation in the early 90s with APIs. Today BPL is one of the largest exporters of medicines from Bangladesh. BPL employs more than 2,400 staff, including over 300 qualified...
Words: 1988 - Pages: 8
...mortality rate of Thai people significant including heart disease and cancer, which are the health problem directly related to consumption is not balanced. Especially in big cities. 4 things to help our health is the balance and not disease including good food, good weather, good temper and good hygiene. But in real, we lives busy and eat fast food, deli food additive, life live in pollution, stress, the pressure from family and work and not enough rest. In modern society, we need to livelihood is under lifestyle and the environment by inevitable. The best choice is to consume for good health and quality. Pharma food product has a similar general deli product. Consumers by unlimited in time and place. There is also an important element of the Functional Ingredients. Research has confirmed the benefits on health, prevent disease and also to create new options in the deli product market to consumers...
Words: 4104 - Pages: 17
...manufacture, test, market, distribute, and seek regulatory approval for their products. However, given the range of factors influencing the business environment, this has also led to a diverse range of organisations competing for unique segments of the market ranging from niche biotechnology operators such as Alexion who are currently establishing a base for the global supply of treatments for severe and ultra rare disorders in Ireland and diversified global players such as Johnson and Johnson who operate across extensive consumer health, medical device and pharmaceutical sectors. PESTEL Analysis Below is an analysis of the macro environmental factors at play in the Pharmaceutical Industry using the PESTEL (Political, Economic, Socio-cultural, Technological, Environmental and Legal) model. The model seeks to identify the issues that impact the sector in a broad context and how these factors influence the strategy of the industry in...
Words: 2748 - Pages: 11
...Definition of Strategy Definition of Strategy: Strategy is a method or plan by which long term objectives will be achieved. Long term objectives are the specific result that an organization seeks to achieve in pursuing its basic mission. Business strategies may involve geographic expansion, diversification, acquisition, product development, market penetration, retrenchment, divestiture, liquidation and joint ventures. Strategies are potential actions that require top management decision and large amount of farm’s resources. Additionally strategies affect an organization’s long term prosperity, typically for at least five years, and thus are future oriented. Strategies have multifunctional and multidivisional consequences and required consideration of both the external and internal factors facing the firm. Most Strategic Management Model There are several Strategic Models are available and used in different organizations but following are the most used strategic models: 1. PEST analysis 2. STEER Analysis 3. Five Forces Model 4. Strategic Group Map 5. SWOT analysis 6. Blue Ocean Strategies 7. Open innovation 8. McKinsey seven S model Company Detailed Profile including mission & vision and Organogram Company Detail Profile Square pharmaceutical is now the most leading company in Bangladesh since 1985 and is now on its way to becoming a high performance global player. Today it has achieved a state of mind among consumers...
Words: 5122 - Pages: 21
...Statement Analysis & Valuation AMBEE PharmaceuticalsLtd. ENTERPRISE VALUATION & ANALYSIS OF BUSINESS AMBEE Pharmaceuticals Limited T able of Contents Chapter - 01 Chapter - 02 Chapter - 03 Chapter - 04 Chapter - 05 About the Company Strategy Analysis Valuation Conclusion Annexure ………………………… ………………………… ………………………… ………………………… 01 03 11 21 A M B E E P H A R M A : V A L U A T I O N 1 Chapter About the Company The company’s operation & historical performances were moderate and they were not leading the market from their inception A MBEE PHARMACEUTICALS LTD., was established in 1976 in Bangladesh. This public limited company was registered under the companies Act, 1913 and was incorporated in Bangladesh on 4th February 1976. Ambee has a joint venture with a famous multinational company Medimpex of Hungary. Ambee started its operation with modest 17 joint ventured products and is now running in full swing with 76 products. They have Tablets, Capsules, Liquids, and Gel in tubes and Injectables. Its operational area covers all over Bangladesh with a large number of field forces who strive hard to establish the demand of products of the company in every corner of the country. The company maintains four outside Depots located at Khulna, Bogra, Chittagong and Sylhet besides its National Distribution Cell in Dhaka. When Ambee Pharmaceutical Ltd.(APL) was launched back in Feb’ 1976, Ambee had only 30 field forces who had launched 17 products only. In the...
Words: 5420 - Pages: 22
...INDUSTRY ANALYSIS 7 2.1 Rivalry among existing firms 7 2.2 Threat of entry of new firms 9 2.3 Threat of Substitute products or Services 10 2.4 Bargaining power of suppliers 10 2.5 Bargaining power of buyers 11 CHAPTER 03: COMPANY ANALYSIS 13 3.1 SWOT ANALYSIS 13 3.1.1 STRENGTHS: 13 3.1.2 WEAKNESSES: 14 3.1.3 OPPORTUNITIES: 14 3.1.4 THREATS: 15 3.2 Competitive Strategy Analysis: 16 3.2.1 Advantage of SPL in using an Integrated Strategy: 17 3.2.2 Disadvantages of SPL in using an Integrated Strategy: 17 CHAPTER 01: COMPANY OVERVIEW 1.1 Introduction The flagship company of the Square group of industries, Square Pharmaceuticals Limited (SPL) is the largest pharmaceuticals company in Bangladesh. Founded in 1958 and headquartered in Dhaka, Bangladesh, SPL develops, manufactures and markets drugs for humans and the animal world. The company owns and operates modern pharmaceutical factories mainly in Bangladesh and also has a separate division to operate a modern chemical factory which produces and sells basic chemical products. It also has divisions to produce and sell agrovet and pesticide products. It exports its products to Europe, Asia, Africa and South America. SQUARE Pharmaceuticals Limited (SPL) is the largest pharmaceutical company in Bangladesh and is leading the Pharmaceuticals sector from the very beginning. It has been continuously in the 1st position among all national and multinational companies since 1985. SPL offers a range of pharmaceutical products, which...
Words: 3682 - Pages: 15
...dedicated professionals guided by an able leadership. Proper strategic planning, technical excellence, swift and timely decisions helped us achieve our objectives leading to much faster growth. Incepta was able to anticipate the need of the market and provide the right product at the right time. High focus on R&D investment from the very beginning made possible the introduction of quality products ahead of its competitors in most cases. Incepta Pharmaceuticals Ltd. is now the 2nd largest company of the country and recognized as the fastest growing of the top five manufacturing company in the country. Incepta now has one of the largest and competent sales force and large distribution network of its own, operated from 18 different locations throughout the country. A marketing team composed of pharmacists and doctors are at the core of the marketing operation. These professionals play a crucial role in providing the necessary strategic guideline for the promotion of its product. The company has very innovative plan to become a most renowned pharmaceutical company in the world by improving research based dosage form manufacturing within a very short period. Product Profiles Incepta Pharmaceuticals was produced its first product, ranitidine, in December of 1999. The company produces various types of dosage forms which include tablets, capsules, oral liquids, ampoules, dry powder vials, powder for suspension, nasal sprays, eye drops, creams, ointments, lotions, gels, prefilled syringes...
Words: 1959 - Pages: 8
...1211132 Tanveer Mohd Ansari-1211151 Contents Introduction .................................................................................................................................................. 3 Global Pharma Industry ............................................................................................................................ 3 Major players of the world pharmaceutical industry ................................................................................... 5 Major Players ............................................................................................................................................ 6 Pfizer Inc................................................................................................................................................ 6 GlaxoSmithKline .................................................................................................................................... 6 Sanofi-Aventis ....................................................................................................................................... 6 Novartis ................................................................................................................................................. 6 Indian Pharma Industry................................................................................................................................. 7 Drivers of the Demand ........................................................
Words: 7934 - Pages: 32
...medicines. In 2010, the pharmaceutical sector employed approximately 272,000 people (source: Bureau of Labor Statistics), and according to the Pharmaceutical Research and Manufacturers of America (Parma), those manufacturers spent $67.4 billion on research and development in 2010. The markets for biologics, over-the-counter (OTC) medicines, and generics show the most potential for growth and have become increasingly competitive. Biologics, valued at $67 billion in 2010 (source: IMS Health), account for a quarter of all new drugs in clinical trials or awaiting Food and Drug Administration approval. OTC market growth will be driven by a growing aging population and consumer trend to self-medication and the conversion of drugs from prescription to non-prescription or OTC status. Generic drug sales in the United States were valued at $78 billion in 2010 (source: IMS Health). The U.S. market is the world’s largest free-pricing market for pharmaceuticals and has a favorable patent and regulatory environment. Product success is largely based on competition in product quality, safety and efficacy, and price. U.S. government support of biomedical research, along with its unparalleled scientific and research base and innovative biotechnology sector, make the U.S. market the preferred home for growth in the pharmaceutical industry. OVERVIEW OF THE USA PHARMACEUTICAL...
Words: 3366 - Pages: 14
...Chandramohanan (1311134) PGP 2013-2015 Under the Guidance of Rishikesha T Krishnan Professor Chairperson, Corporate Strategy & Policy Area Under the Guidance of Rishikesha T Krishnan Professor Chairperson, Corporate Strategy & Policy Area Contents Introduction 2 Financial Analysis: 2 Resources 3 Current Challenges: 6 Current Strategy: 6 Key Recommendations: 7 Elaboration: 8 Plan for Implementation: 9 Financial Forecast: 11 Contingency Plan: 11 Alternatives 11 Appendix: 11 Introduction Dr. Reddy’s Laboratories started as a primary API manufacturer to cater to the Indian and international markets. Later DR Reddy’s pioneered the operations formulations and today, it is one of the most established companies in the Indian and Global pharmaceutical industry. DRL is a 200 million dollar venture with presence in almost all major therapeutic areas, providing affordable and innovative medicines in all major therapeutic areas like gastro-intestinal, oncology, pain management, cardiovascular, dermatology, diabetes, etc. DRL operates in three business segments- Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products. Its Indian manufacturing operations were strengthened by acquiring American Remedies Ltd and this acquisition made Reddy’s the third...
Words: 4430 - Pages: 18
...world renowned companies like Upjohn Inc. of USA and Bayer AG of Germany. Since the very beginning, the company was highly successful in generating increased demand for its products which eventually justified local production. It completed its registration in 1976 and started its operation in 1980 by manufacturing and marketing licensee products of Bayer AG of Germany and Upjohn Inc. of USA. After its initial years of struggle it broke ground with the launching of its own products in 1983. In 1985 BPL was listed in Dhaka Stock Exchange (DSE) as a Public Limited Company. The journey continued and barrier after barrier were crossed, challenges were faced and overcome to transform BPL into what it is at present. Now it has grown to become nation's one of the leading pharmaceutical companies, supplying more than 10% of the country's total medicine need. In the process, it was enlisted in Chittagong and London Stock Exchange. Today Beximco manufactures and markets its own `branded generics' for almost all diseases from AIDS to cancer, from infection to asthma, from hypertension to diabetes for both national and international markets ( Beximco Pharmaceutical Ltd, 2013). Beximco has a strong market focus and is anticipating continued future growth by leveraging business capabilities and developing superior product brands and markets. In particular it is very interested in developing a strong export market in USA and Europe. To meet the future demand it has invested over US 50 million...
Words: 4414 - Pages: 18
...industry, as well as the economic characteristics, performance, and the impact of the global recession. The industry is made up of several enterprises engaging in the research, development, manufacture and marketing of medicines, vaccines, medical devices, and nutritional products for humans and animals. Though, this multi-billion dollar industry includes large ethical drug multi-nationals (often referred to as Big Pharma), mid-sized specialty pharmaceutical companies, manufacturers of generics, small biotechnology and biopharmaceutical firms, and service companies, 1 for the purpose of this paper, the emphasis will be mainly on drug makers. 2. History/Overview of the Industry The pharmaceutical industry of today is a far cry from its humble beginnings in the nineteenth century of physicians mainly prescribing plant extracts to being technology intensive, dominated by a few large companies with significant research and development (R&D) budgets, and significant government oversight. Over the past five years, the industry has been characterized by mega-mergers and acquisitions, company reorganizations, regulatory reform, expiring patent protection, and the growth of generics. Figure 1. Big Pharma Top 10 for 2010 The United States is the largest...
Words: 2796 - Pages: 12
...Internship Report On Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review Of Costing Function ‘Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review Of Costing Function’ by Syeda Afrina Sarwar ID: 07304063 BRAC Business School BRAC University, Bangladesh August 2011 ‘Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review Of Costing Function’ Submitted By: Syeda Afrina Sarwar ID: 07304063 BRAC Business School Submitted To: ------------------------------------------------Ms. Rahnuma Ahmed Lecturer BRAC Business School BRAC University, Bangladesh August 2011 Letter of Transmittal August 10, 2011 Ms. Rahnuma Ahmed Lecturer BRAC BUSINESS SCHOOL BRAC University 66, Mohakhali Dhaka-1212 Subject: Submission of Internship Report Dear Madam, I am submitting an internship report titled for ‘Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review of Costing Function’ as a part of the requirement of the course. Your guideline has been followed in every aspect of preparing this report. I have really enjoyed working on this project and I hope that my work would meet the level of your expectation. Any query on this report is appreciated. Thank You. Sincerely, Syeda Afrina Sarwar ID:07304063 Acknowledgement It’s difficult for me to thank all of those marvelous people who have contributed something of them to this report. There are of course some very special people who cannot go...
Words: 15094 - Pages: 61
...1) Pharmaceutical Industry in India: India is the third largest pharmaceutical market in the world in terms of volume. The market is believed to grow at a compound annual growth rage (CAGR) of 14-17 percent in between 2012-16. There has also been a considerable growth in the levels of pharmaceutical exports from India. The industry started picking momentum in the early 1960s, with government actively encouraging the sector with the Patents Act. However, the liberalization of 1991 enabled the industry to become what it is today. Many of the Indian companies principally observe reverse engineering of the new processes for manufacturing drugs at low costs. Although some of the companies have taken baby steps towards innovating newer drugs, the industry as a whole tends to follow this business model. The lack of patent protection, on the other hand, makes India undesirable for multinational companies that have dominated the market. So the pharmaceutical market in India has a tremendous potential for indigenousness. In this context, comparing a global pharmaceutical company with its Indian counterpart becomes evident. GlaxoSmithKline and Ranbaxy: A Comparison GlaxoSmithKline is a British multinational pharmaceutical company also dealing in biologics, vaccines and consumer healthcare. Headquartered at London, it is the world’s sixth largest pharmaceutical company. The company was established in 2000 by the merger of Glaxo Wellcome and SmithKline Beckman Corporation. A giant...
Words: 3952 - Pages: 16